Acute kidney injury biomarkers for patients in a coronary care unit: A prospective cohort study

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Chen, Tien Hsing ^a   Chang, Chih Hsiang ^a   Lin, Chan Yu ^a   Jenq, Chang Chyi ^a,b   Chang, Ming Yang ^a,b   Tian, Ya Chung ^a,b   Hung, Cheng Chieh ^a,b   Fang, Ji Tseng ^a,b   Yang, Chih Wei ^a,b   Wen, Ming Shien ^a,b   Lin, Fun Chung ^a,b   Chen, Yung Chang ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CONTRAST MEDIUM; CREATININE; CYSTATIN C; GLUCOSE; HEMOGLOBIN; HIGH SENSITIVITY C REACTIVE PROTEIN; INOTROPIC AGENT; INTERLEUKIN 18; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SERUM ALBUMIN; SODIUM; TROPONIN I; UNCLASSIFIED DRUG; VASOACTIVE AGENT; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; AGE; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY CARE UNIT; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DRUG EXPOSURE; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; INJURY SEVERITY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEDICAL HISTORY; MORTALITY; OVERALL SURVIVAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEPSIS; SODIUM BLOOD LEVEL; SURVIVAL RATE; SURVIVOR; YOUDEN INDEX; CARDIOLOGY; CARDIOVASCULAR DISEASE; METABOLISM; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; AGED; APACHE; BIOLOGICAL MARKERS; CARDIOLOGY; CARDIOVASCULAR DISEASES; CORONARY CARE UNITS; CREATININE; CYSTATIN C; FEMALE; HUMANS; INTERLEUKIN-18; LIPOCALINS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROTO-ONCOGENE PROTEINS; TREATMENT OUTCOME;

EID: 84863156563     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032328     Document Type: Article

References (39)

1. Schrier RW, Wang W, Poole B, Mitra A, (2004) Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114: 5-14.
2. Chen YC, Tsai FC, Chang CH, Lin CY, Jenq CC, et al. (2011) Prognosis of patients on extracorporeal membrane oxygenation: the impact of acute kidney injury on mortality. Ann Thorac Surg 91: 137-142.
3. Hoste EA, De Waele JJ, Gevaert SA, Uchino S, Kellum JA, (2010) Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis. Nephrol Dial Transplant 25: 747-758.
4. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW, (1997) Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103: 368-375.
5. Tomlanovich S, Golbetz H, Perlroth M, Stinson E, Myers BD, (1986) Limitations of creatinine in quantifying the severity of cyclosporine-induced chronic nephropathy. Am J Kidney Dis 8: 332-337.
6. Parikh CR, Devarajan P, (2008) New biomarkers of acute kidney injury. Crit Care Med 36: S159-S165.
7. Coca SG, Yalavarthy R, Concato J, Parikh CR, (2008) Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 73: 1008-1016.
8. Thygesen K, Alpert JS, White HD, on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction (2007) Universal definition of myocardial infarction. Circulation 116: 2634-2653.
9. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D, (1993) Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88: 107-115.
10. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864-874.
11. Knaus WA, Draper EA, Wagner DP, Zimmerman JE, (1985) APACHE II: a severity of disease classification system. Crit Care Med 13: 818-824.
12. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, et al. (2007) Acute Kidney Injury Network.: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11: R31.
13. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, et al. (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17: 2937-2944.
14. DeLong E, DeLong D, Clarke-Pearson D, (1998) Comparing the areas under two or more correlated receiver operating characteristic curves: a non-parametric approach. Biometrics 44: 837-844.
15. Youden WJ, (1950) Index for rating diagnosis tests. Cancer 3: 32-35.
16. McCullough PA, Soman SS, Shah SS, Smith ST, Marks KR, et al. (2000) Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol 36: 679-684.
17. Cadnapaphornchai MA, Gurevich AK, Weinberger HD, Schrier RW, (2001) Pathophysiology of sodium and water retention in heart failure. Cardiology 96: 122-131.
18. Westhuyzen J, Cystatin C, (2006) A promising marker and predictor of impaired renal function. Ann Clin Lab Sci 36: 387-394.
19. Herget-Rosenthal S, Bokenkamp A, Hofmann W, (2007) How to estimate GFR serum creatinine, serum cystatin C or equations? Clin Biochem 40: 153-161.
20. Krawczeski CD, Vandevoorde RG, Kathman T, Bennett MR, Woo JG, et al. (2010) Serum cystatin C is an early predictive biomarker of acute kidney injury after pediatric cardiopulmonary bypass. Clin J Am Soc Nephrol 5: 1552-1557.
21. Perianayagam MC, Seabra VF, Tighiouart H, Liangos O, Jaber BL, (2009) Serum cystatin C for prediction of dialysis requirement or death in acute kidney injury: a comparative study. Am J Kidney Dis 54: 1025-1033.
22. Heise D, Rentsch K, Braeuer A, Friedrich M, Quintel M, (2011) Comparison of urinary neutrophil glucosaminidase-associated lipocalin, cystatin C, and alpha(1)-microglobulin for early detection of acute renal injury after cardiac surgery. Eur J Cardiothorac Surg 39: 38-43.
23. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, et al. (2005) Neutrophil gelatinaseassociated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365: 1231-1238.
24. Damman K, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL, (2008) Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail 10: 997-1000.
25. Hemdahl AL, Gabrielsen A, Zhu C, Eriksson P, Hedin U, et al. (2006) Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol 26: 136-142.
26. Bu DX, Hemdahl AL, Gabrielsen A, Fuxe J, Zhu C, et al. (2006) Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB. Am J Pathol 169: 2245-2253.
27. Hall IE, Yarlagadda SG, Coca SG, Wang Z, Doshi M, et al. (2010) IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol 21: 189-197.
28. Carlson M, Raab Y, Sevéus L, Xu S, Hällgren R, et al. (2002) Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut 50: 501-506.
29. Blankenberg S, Luc G, Ducimetière P, Arveiler D, Ferrières J, et al. (2003) Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 108: 2453-2459.
30. Tiret L, Godefroy T, Lubos E, Nicaud V, Tregouet DA, et al. (2005) Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 112: 643-650.
31. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, et al. (1998) Targeted disruption of the MyD88 gene results in loss of IL-1 and IL-18 mediated function. Immunity 9: 143-150.
32. Matsumoto S, Tsuji Takayama K, Aizawa Y, Koide K, Takeuchi M, et al. (1997) Interleukin-18 activates NF-kappaB in murine Thelper type 1 cells. Biochem Biophys Res Commun 234: 454-457.
33. Lee JK, Kim SH, Lewis EC, Azam T, Reznikov LL, et al. (2004) Differences in signaling pathways by IL-1beta and IL-18. Proc Natl Acad Sci U S A 101: 8815-8820.
34. Li S, Goorha S, Ballou LR, Blatteis CM, (2003) Intracerebroventricular interleukin-6, macrophage inflammatory protein-1 beta and IL-18: pyrogenic and PGE(2)-mediated? Brain Res 992: 76-84.
35. Netea MG, Kullberg BJ, van der Meer JW, (2000) Circulating cytokines as mediators of fever. Clin Infect Dis 31: S178-184.
36. Thompson SR, McCaskie PA, Beilby JP, Hung J, Jennens M, et al. (2007) IL-18 haplotypes are associated with serum IL-18 concentrations in a population-based study and a cohort of individuals with premature coronary heart disease. Clin Chem 53: 2078-2085.
37. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310.
38. Siew ED, Ware LB, Ikizler TA, (2011) Biological markers of acute kidney injury. J Am Soc Nephrol 22: 810-820.
39. Koyner JL, Vaidya VS, Bennett MR, Ma Q, Worcester E, et al. (2010) Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 5: 2154-2165.